Joseph T Kennedy's Net Worth

$39 Million

Estimate Recalculated Nov 1, 2024 06:37AM EST

Who is Joseph T Kennedy?

Joseph T Kennedy has an estimated net worth of $39 Million. This is based on reported shares across multiple companies, which include AMARIN CORP PLC\UK, and Transcept Pharmaceuticals Inc.

SEC CIK

Joseph T Kennedy's CIK is 0001408920

Past Insider Trading and Trends

2019 was Joseph T Kennedy's most active year for acquiring shares with 49 total transactions. Joseph T Kennedy's most active month to acquire stocks was the month of December. 2019 was Joseph T Kennedy's most active year for disposing of shares, totalling 59 transactions. Joseph T Kennedy's most active month to dispose stocks was the month of December. 2019 saw Joseph T Kennedy paying a total of $5,469,469.27 for 1,478,629 shares, this is the most they've acquired in one year. In 2019 Joseph T Kennedy cashed out on 2,663,233 shares for a total of $26,293,252.85, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094

General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.09%
3.42K
$4.14
-$15,744.42
317.86K
Jul 30
Form 4
+1.10%
3.42K
$4.48
-$17,037.44
314.44K
Jun 30
Form 4
+1.11%
3.42K
$4.54
-$17,265.62
311.03K
May 28
Form 4
+1.12%
3.42K
$5.24
-$19,927.72
307.61K
Apr 30
Form 4
+1.14%
3.42K
$6.37
-$24,225.11
304.19K
Mar 31
Form 4
+25.31%
60.74K
$7.20
-$486,124.96
300.77K
Feb 25 - Feb 26
Form 4
+11.96%
25.63K
$7.50
-$125,332.50
240.03K
Jan 29
Form 4
+0.80%
1.71K
$5.23
-$9,947.46
214.4K
Dec 31 - Jan 4
Form 4
+0.81%
1.71K
$4.60
-$8,749.20
212.69K
Nov 30
Form 4
+0.82%
1.71K
$4.86
-$9,243.72
210.98K
Oct 30
Form 4
+1.76%
3.61K
—
—
209.27K
Sep 30
Form 4
+0.84%
1.71K
$7.36
-$13,998.72
205.66K
Aug 31
Form 4
+0.84%
1.71K
$6.59
-$12,547.36
203.95K
Jul 31
Form 4
+0.85%
1.71K
$6.72
-$12,781.44
202.24K
Jun 30
Form 4
+0.86%
1.71K
$6.86
-$13,047.72
200.53K
May 29
Form 4
+0.87%
1.71K
$8.26
-$15,710.52
198.83K
Apr 30
Form 4
+1.87%
3.61K
—
—
197.12K
Mar 31
Form 4
+1.90%
3.61K
—
—
193.51K
Feb 28 - Mar 2
Form 4
+18.08%
29.07K
$17.58
-$568,255.92
189.9K
Feb 25
Form 4
+27.92%
35.1K
$19.04
-$754,593.28
160.82K
Jan 31 - Feb 3
Form 4
+302.18%
94.46K
$14.37
-$1,509,381.69
125.72K
Oct 7
Form 4
-46.29%
-26.94K
$11.05
-$987,943.69
31.26K
Scheduled
Jul 1
Form 4
+86.19%
26.94K
$19.39
-$513,738.05
58.2K
Scheduled
Jun 30
Form 4
—
0
$10.25
-$418,133.44
31.26K
Scheduled
May 31
Form 4
—
0
$10.63
-$438,911.74
31.26K
Scheduled
Apr 30
Form 4
+7.11%
2.22K
$11.78
-$1,613,029.63
31.26K
Scheduled
Mar 31 - Apr 1
Form 4
—
0
$11.65
-$494,243.36
31.26K
Scheduled
Feb 28
Form 4
∞
31.26K
$9.84
-$1,490,184.47
31.26K
Scheduled
Jan 31 - Feb 1
Form 4
-100.00%
-217.93K
$11.93
-$13,472,508.77
0
Scheduled
Jan 22 - Jan 24
Form 4
—
0
$10.94
-$50,672.81
217.93K
Scheduled
Jan 11
Form 4
—
0
$13.37
-$714,341.09
217.93K
Scheduled
Dec 31
Form 4
—
0
$10.03
-$362,488.13
217.93K
Scheduled
Nov 30
Form 4
—
0
$11.50
-$430,849.59
217.93K
Scheduled
Oct 31
Form 4
—
0
$9.44
-$1,275,602.00
217.93K
Scheduled
Sep 30 - Oct 1
Form 4
—
0
$6.39
-$9,007,961.27
217.93K
Scheduled
Sep 24
Form 4
+1,082.24%
199.5K
—
—
217.93K
Sep 22
Form 4
—
0
$3.05
-$162,824.87
18.43K
Scheduled
Jun 30 - Jul 2
Form 4
—
0
$2.95
-$157,822.09
18.43K
Scheduled
Mar 31 - Apr 3
Form 4
∞
18.43K
$3.79
-$398,387.17
18.43K
Scheduled
Jan 31 - Feb 1
Form 4
-100.00%
-51.11K
$4.10
-$209,449.80
0
Scheduled
Jan 12 - Jan 17
Form 4
+100.00%
25.55K
$4.01
-$111,818.85
51.11K
Dec 31
Form 4
∞
25.55K
$3.50
-$97,597.50
25.55K
Sep 30
Form 4
-100.00%
-282.36K
$4.00
-$1,343,309.35
0
Scheduled
May 15 - Jul 3
Form 4
+10.34%
26.46K
$3.20
-$86,339.20
282.36K
Mar 31
Form 4
+36.36%
68.23K
$2.97
-$225,348.75
255.9K
Jan 31 - Feb 1
Form 4
+15.76%
25.55K
$3.08
-$85,885.80
187.67K
Dec 31
Form 4
-43.01%
-122.36K
$3.04
-$372,041.73
162.12K
Nov 9
Form 4
+9.87%
25.55K
$3.19
-$88,953.15
284.48K
Sep 30
Form 4
+10.95%
25.55K
$2.16
-$60,231.60
258.93K
Jun 30
Form 4
+16.68%
33.35K
$1.53
-$30,725.46
233.37K
Mar 31
Form 4
+53.67%
69.86K
$1.36
-$64,710.16
200.02K
Jan 31 - Feb 1
Form 4
+34.46%
33.36K
$1.89
-$37,954.98
130.16K
Dec 31
Form 4
+4.20%
3.9K
$2.05
-$4,815.45
96.81K
Oct 5
Form 4
+46.42%
29.45K
$1.93
-$34,226.62
92.9K
Sep 30
Form 4
—
0
—
—
0
Jul 6
Form 4
+812.95%
56.5K
—
—
63.45K
Jan 31 - Feb 2
Form 4
—
0
—
—
0
Jan 8
Form 4
∞
6.95K
—
—
6.95K
Jul 26 - Jul 26
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
$13.85
-$96,290.36
0
Scheduled
Jul 26 - Jul 27
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Dec 16
Form 3
—
0
—
—
0
No matching records found

Transcept Pharmaceuticals Inc No price found

VP and General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$5.65
-$313,881.12
0
Scheduled
Dec 1
Form 4
—
0
$5.28
-$179,401.00
0
Scheduled
Nov 23
Form 4
—
0
—
—
0
Aug 24
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
—
—
0
Jan 14
Form 4
—
0
—
—
0
Mar 12
Form 3
—
0
—
—
0
No matching records found